| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
| 08/07/2007 | CA2252374C A process for viral inactivation of lyophilized blood proteins |
| 08/07/2007 | CA2246378C Isolation and use of sh3 binding peptides |
| 08/07/2007 | CA2239702C Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 08/07/2007 | CA2182888C Nucleotide and amino acid sequences of canine herpesvirus gb, gc and gd and uses therefor |
| 08/07/2007 | CA2151563C Preparation of stable zinc insulin analog crystals |
| 08/07/2007 | CA2115565C Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 08/07/2007 | CA2071863C Recombinant vaccine for porcine pleuropneumonia |
| 08/07/2007 | CA2062829C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 08/02/2007 | WO2007087576A2 Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases |
| 08/02/2007 | WO2007087508A2 Lipase variants |
| 08/02/2007 | WO2007087492A2 Methods and compositions for modulating tocopherol and tocotrienol content in plants |
| 08/02/2007 | WO2007087412A2 Tat-036 and methods of assessing and treating cancer |
| 08/02/2007 | WO2007087370A2 Tat-038 and methods of assessing and treating cancer |
| 08/02/2007 | WO2007087318A2 Detergent compositions |
| 08/02/2007 | WO2007087131A2 Peptide prodrugs |
| 08/02/2007 | WO2007086932A2 Prostate stem cell antigen vaccines and uses thereof |
| 08/02/2007 | WO2007086904A2 Compositions for use in identification of adenoviruses |
| 08/02/2007 | WO2007086882A2 Biological polymer with differently charged portions |
| 08/02/2007 | WO2007086645A1 Fusaricidin synthetase and gene thereof |
| 08/02/2007 | WO2007086619A1 Modified glycoprotein having unsaturated functional group |
| 08/02/2007 | WO2007086613A1 Enzymatically crosslinked protein nanoparticles |
| 08/02/2007 | WO2007086547A1 A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE yrbG GENE |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086473A1 Method of changing fluorescence wavelength of fluoroprotein |
| 08/02/2007 | WO2007086402A1 Plant stomatal regulatory factor |
| 08/02/2007 | WO2007086342A1 METHOD OF DETECTING CANCER USING SPLICING VARIANT OF c-myc GENE TRANSCRIPTIONAL REGULATOR FIR OR FOUR-BASE REPETITIVE SEQUENCE IN INTRON 2 |
| 08/02/2007 | WO2007085923A2 Novel fluorescent proteins and methods for using same |
| 08/02/2007 | WO2007085887A1 Pyy agonists and uses thereof |
| 08/02/2007 | WO2007085879A1 Compositions containing substances obtained from the blood and other biological fluid of snake : methods for their preparation and their use |
| 08/02/2007 | WO2007085846A1 Use of a vegf binding peptide to retard hair growth |
| 08/02/2007 | WO2007085630A1 Human semen enhancer of viral infection peptides (sevi) and their use |
| 08/02/2007 | WO2007085596A1 Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium |
| 08/02/2007 | WO2007085412A1 Fgf2-binding peptides and uses thereof |
| 08/02/2007 | WO2007085240A1 Method for immunoadsorption by means of autoantigens |
| 08/02/2007 | WO2007085238A2 Multifunctional mixture of active substances |
| 08/02/2007 | WO2007085087A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 08/02/2007 | WO2007085084A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | WO2007057665A3 Detection of human platelet antigen (hpa) antibodies |
| 08/02/2007 | WO2007057618A3 Inducible promoters |
| 08/02/2007 | WO2007056174A3 Transgenic mouse for elucidating the function of alpha1-adrenergic receptors |
| 08/02/2007 | WO2007055996A3 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| 08/02/2007 | WO2007052067A3 Von willebrand factor (vwf) binding peptides |
| 08/02/2007 | WO2007050043A3 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates |
| 08/02/2007 | WO2007047728A3 Compositions and methods for the treatment of canine influenza virus disease |
| 08/02/2007 | WO2007044912A3 Non-native constitutively active osteopontin |
| 08/02/2007 | WO2007044607A3 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 08/02/2007 | WO2007042326A3 Neisseria meningitidis antigens |
| 08/02/2007 | WO2007042166A3 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 08/02/2007 | WO2007041216A3 Plasmodium liver stage antigens |
| 08/02/2007 | WO2007034166A3 Adjuvanted vaccine |
| 08/02/2007 | WO2007030454A3 Mutations and polymorphisms of hdac9 |
| 08/02/2007 | WO2007027776A3 Insecticidal compositions and methods for making insect-resistant transgenic plants |
| 08/02/2007 | WO2007020617A3 Sequences of megaplasmid pmp118, chromosomal sequences and individual sequences thereof of lactobacillus salivarius strain ucc118 |
| 08/02/2007 | WO2007015783A3 Attenuated strains of flaviviruses , and uses thereof |
| 08/02/2007 | WO2007002233A3 Low-toxicity, long-circulating chimeras of human interferon- alpha analogs and interferon tau |
| 08/02/2007 | WO2006112552A3 Therapeutic agents for abeta related disorders |
| 08/02/2007 | WO2006112551A3 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 08/02/2007 | WO2006099160A3 Bioluminescence resonance energy transfer (bret) systems and methods of use thereof |
| 08/02/2007 | WO2006093552A3 Second tc complex from xenorhabdus |
| 08/02/2007 | WO2006084129A3 Genes of porphyromonas gingivalis w83 involved in invasion of human cells |
| 08/02/2007 | WO2006084027A3 Sipa-1 gene and sipa-1 inhibitor for the treatment, prevention, and diagnosis of cancer |
| 08/02/2007 | WO2006068867A9 Combination therapy for b cell disorders |
| 08/02/2007 | WO2005079343A3 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 08/02/2007 | WO2005067957A3 Use of a dg147 protein product for preventing and treating metabolic disorders |
| 08/02/2007 | WO2005037858A3 Template-directed assembly of receptor signaling complexes |
| 08/02/2007 | WO2005035722A3 Variant polypeptides containing plekstrin homology domains and uses therefor |
| 08/02/2007 | WO2005019264A3 Human lxr alpha variants |
| 08/02/2007 | WO2005012545A3 Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors |
| 08/02/2007 | WO2004033637A3 Extracellular messengers |
| 08/02/2007 | WO2004013292A3 Extracellular messengers |
| 08/02/2007 | WO2002072611A8 Novel human egf-family proteins and polynucleotides encoding the same |
| 08/02/2007 | US20070180584 Transcription factor gene induced by water deficit conditions and abscisic acid from helianthus annuus, promoter and transgenic plants |
| 08/02/2007 | US20070180582 Transgenic plants for use in enhanced food production in farming; mitochondrial gene transfer; increased storage stability |
| 08/02/2007 | US20070180581 Flower-bud formation suppressor gene and early flowering plant |
| 08/02/2007 | US20070180544 Methods and compositions for autism spectrum disorders |
| 08/02/2007 | US20070180543 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
| 08/02/2007 | US20070179284 insecticidal proteins encoded by naturally-occurring and recombinant nucleic acids, has the activity against plant pathogens |
| 08/02/2007 | US20070179283 Extraction process for a pharmaceutical product |
| 08/02/2007 | US20070179282 Pressure cryocooling protein crystals |
| 08/02/2007 | US20070179281 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 08/02/2007 | US20070179278 HIV fusion inhibitor peptides with improved biological properties |
| 08/02/2007 | US20070179094 Modulation of MDL-1 activity for treatment of inflammatory disease |
| 08/02/2007 | US20070179093 Growth factor modified protein matrices for tissue engineering |
| 08/02/2007 | US20070179092 Method of Enhancing Neural Stem Cell Proliferation, Differentiation, and Survival Using Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) |
| 08/02/2007 | US20070179090 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 08/02/2007 | US20070179089 Structure of SOCS and uses thereof |
| 08/02/2007 | US20070179086 Polypeptides and antibodies |
| 08/02/2007 | US20070178592 Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same |
| 08/02/2007 | US20070178576 Purification of high-molecular compounds by means of affinity membrane chromatography |
| 08/02/2007 | US20070178563 Mosaic infectious bursal disease virus vaccines |
| 08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
| 08/02/2007 | US20070178559 Platelet promoting protein and the usage thereof |
| 08/02/2007 | US20070178555 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 08/02/2007 | US20070178554 Orthogonal Aminoacyl Synthetase-tRNA Pairs for Incorporating Unnatural Amino Acids Into Proteins |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178551 Methods for producing modified glycoproteins |
| 08/02/2007 | US20070178540 Goodpasture antigen binding protein |
| 08/02/2007 | US20070178539 Novel Cytokine Receptors and Nucleic Acids Encoding the Same |
| 08/02/2007 | US20070178532 Identification, quantification, and characterization of t cells and t cell antigens |